Related Experiment Video
Updated: Jun 4, 2026

Two- and Three-Dimensional Live Cell Imaging of DNA Damage Response Proteins
Published on: September 28, 2012
L1CAM regulates DNA damage checkpoint response of glioblastoma stem cells through NBS1
Lin Cheng1, Qiulian Wu, Zhi Huang
1Department of Stem Cell Biology and Regenerative Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.
Abstract:
Glioblastomas (GBMs) are highly lethal brain tumours with current therapies limited to palliation due to therapeutic resistance. We previously demonstrated that GBM stem cells (GSCs) display a preferential activation of DNA damage checkpoint and are relatively resistant to radiation. However, the molecular mechanisms underlying the preferential checkpoint response in GSCs remain undefined. Here, we show that L1CAM (CD171) regulates DNA damage checkpoint responses and radiosensitivity of GSCs through nuclear translocation of L1CAM intracellular domain (L1-ICD). Targeting L1CAM by RNA interference attenuated DNA damage checkpoint activation and repair, and sensitized GSCs to radiation. L1CAM regulates expression of NBS1, a critical component of the MRE11-RAD50-NBS1 (MRN) complex that activates ataxia telangiectasia mutated (ATM) kinase and early checkpoint response. Ectopic expression of NBS1 in GSCs rescued the decreased checkpoint activation and radioresistance caused by L1CAM knockdown, demonstrating that L1CAM signals through NBS1 to regulate DNA damage checkpoint responses. Mechanistically, nuclear translocation of L1-ICD mediates NBS1 upregulation via c-Myc. These data demonstrate that L1CAM augments DNA damage checkpoint activation and radioresistance of GSCs through L1-ICD-mediated NBS1 upregulation and the enhanced MRN-ATM-Chk2 signalling.
Insights
L1CAM protein enhances brain tumor stem cell resistance to radiation therapy by regulating DNA repair. Targeting L1CAM may improve glioblastoma treatment outcomes.
Area of Science:
- Neuro-oncology
- Cancer Biology
- Molecular Oncology
Background:
- Glioblastomas (GBMs) are aggressive brain tumors with limited treatment options due to therapeutic resistance.
- Glioblastoma stem cells (GSCs) exhibit enhanced DNA damage checkpoint activation and radioresistance, but the underlying mechanisms are unclear.
Purpose of the Study:
- To elucidate the molecular mechanisms by which L1CAM influences DNA damage checkpoint responses and radiosensitivity in GSCs.
- To investigate the role of L1CAM nuclear translocation and its downstream signaling pathways in GSC radioresistance.
Main Methods:
- Utilized RNA interference to target L1CAM expression in GSCs.
- Assessed DNA damage checkpoint activation, DNA repair capacity, and radiosensitivity following L1CAM manipulation.
- Investigated the expression of NBS1 and the MRE11-RAD50-NBS1 (MRN) complex components.
- Examined the role of L1CAM intracellular domain (L1-ICD) nuclear translocation and c-Myc in regulating NBS1 expression.
Main Results:
- L1CAM knockdown attenuated DNA damage checkpoint activation and repair, increasing GSC radiosensitivity.
- L1CAM regulates the expression of NBS1, a key component of the MRN complex crucial for ATM kinase activation.
- Ectopic NBS1 expression rescued the radioresistance defects caused by L1CAM knockdown.
- Nuclear translocation of L1-ICD mediates NBS1 upregulation via c-Myc, enhancing MRN-ATM-Chk2 signaling.
Conclusions:
- L1CAM plays a critical role in augmenting DNA damage checkpoint activation and radioresistance in GSCs.
- The L1CAM-L1-ICD-NBS1-c-Myc axis is a key pathway regulating GSC response to DNA damage.
- Targeting L1CAM presents a potential therapeutic strategy to overcome radioresistance in glioblastoma.
More Related Videos
Related Concept Videos
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
Negative Regulator Molecules
The Intrinsic Apoptotic Pathway
Abnormal Proliferation

